Compare PGC & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PGC | CTKB |
|---|---|---|
| Founded | 1921 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 453.9M | 433.8M |
| IPO Year | N/A | 2021 |
| Metric | PGC | CTKB |
|---|---|---|
| Price | $27.89 | $4.99 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 4 |
| Target Price | ★ $37.00 | $5.88 |
| AVG Volume (30 Days) | 183.1K | ★ 1.8M |
| Earning Date | 11-07-2025 | 11-05-2025 |
| Dividend Yield | ★ 0.72% | N/A |
| EPS Growth | ★ 6.12 | N/A |
| EPS | ★ 1.93 | N/A |
| Revenue | ★ $248,809,000.00 | $196,828,000.00 |
| Revenue This Year | $27.34 | N/A |
| Revenue Next Year | $16.59 | $5.62 |
| P/E Ratio | $14.49 | ★ N/A |
| Revenue Growth | ★ 18.63 | N/A |
| 52 Week Low | $23.96 | $2.37 |
| 52 Week High | $37.64 | $7.30 |
| Indicator | PGC | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 60.24 | 49.02 |
| Support Level | $26.37 | $5.15 |
| Resistance Level | $28.34 | $5.50 |
| Average True Range (ATR) | 0.84 | 0.37 |
| MACD | 0.30 | -0.09 |
| Stochastic Oscillator | 85.93 | 5.95 |
Peapack Gladstone Financial Corp provides banking services. It operates through two segments namely Banking, which involves the delivery of loans and deposits, and Wealth Management Division which includes asset management services. The banking segment includes commercial real estate, multifamily, residential and consumer lending, deposit generation, and Internet banking services. Wealth Management includes investment management services for individuals and institutions; personal trust services, administrator, custodian and guardians, and other financial planning and advisory services. The services provided by the company include checking and savings accounts, money market and interest-bearing checking accounts, certificates of deposit, individual retirement accounts, and other services.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.